Clinical trial · Observational
Distribution of Bacteria in OME After Radiotherapy For NPC.
Distribution of Bacteria in Otitis Media With Effusion After Radiotherapy For Nasopharyngeal Carcinoma.
NCT06523933CI-TRIAL-00079183unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To observe the prognostic difference of tympanocentesis in different kinds of otitis media effusion.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Nasopharyngeal Carcinoma | Nasopharyngeal Carcinoma | ONTOLOGY_EXACT | 0.98 |
| Otitis Media Effusion | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (4)
- label
- ON+
- description
- Patients with OME after NPC with a Positive Result of Bacteria Culture of Middle Ear Effusion.
- label
- ON-
- description
- Patients with OME after NPC with a Negative Result of Bacteria Culture of Middle Ear Effusion.
- label
- O+
- description
- Patients with OME with a Positive Result of Bacteria Culture of Middle Ear Effusion.
- label
- O-
- description
- Patients with OME with a Negative Result of Bacteria Culture of Middle Ear Effusion.
Primary outcomes (1)
- measure
- Positive Bacterial Culture Rate in Middle Ear Effusion
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 15 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * patients clinical diagnosis of OME or OME after radiotherapy for NPC (Diagnostic criteria: fluid visible in the middle ear and a type B tympanogram). * patients volunteered to participate in the study and signed the informed consent Exclusion Criteria: * NPC recurrence or other malignant tumor after radiotherapy. * clear diagnosis of Eustachian ostium atresia or nasal obstruction diseases, such as severe deviated nasal septum, choanal atresia, osteoradionecrosis of skull base after radiotherapy, etc. * pregnant and lactating women. * patients with severe underlying diseases or with severe liver and kidney dysfunction. * patients who could not cooperate (including poor hearing and radiation encephalopathy) * patients with other middle ear diseases, such as middle ear cholesteatoma, osteoradionecrosis of temporal bone after radiotherapy, etc. * severe deglutition disorders * cleft palate
References
Publications (0)
Data not yet available
No reference posted for this study.